Acute Treatment Now Available in the Home

Acute Treatment Now Available in the Home

We’ve covered BioIntellisense and its clinical grade BioButton wearable sensor several times in the past two years. We also wrote about Medically Home’s at-home hospitalization programs during the COVID-19 pandemic. The two companies recently announced a...
BioButton Wearable Tracks Vitals for 90 Days

BioButton Wearable Tracks Vitals for 90 Days

The global demand for solutions to test for COVID-19 continues to produce results. We’ve written about several technology implementations that monitor biomarkers relevant to the pandemic virus. Earlier this year, we wrote about Denver-based BioIntellisense...